Shanghai Pharmaceuticals Holding Co.Ltd(601607) : Shanghai Pharmaceuticals Holding Co.Ltd(601607) announcement on the change of senior management

Securities code: Shanghai Pharmaceuticals Holding Co.Ltd(601607) securities abbreviation: Shanghai Pharmaceuticals Holding Co.Ltd(601607) No.: pro 2022025 Shanghai Pharmaceuticals Holding Co.Ltd(601607)

Announcement on the change of senior management

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.

Shanghai Pharmaceuticals Holding Co.Ltd(601607) (hereinafter referred to as ” Shanghai Pharmaceuticals Holding Co.Ltd(601607) ” and “the company”) deliberated and approved the proposal on the appointment of senior managers of the company at the 29th meeting of the seventh board of directors held on March 29, 2022, and agreed to appoint Mr. Zhong Tao, Mr. Li Dongming and Mr. Pan Deqing as the vice president of the company, whose term of office expires at the expiration of the seventh board of directors.

Mr. Gu Haoliang, the former vice president of the company, will no longer serve as the vice president of the company since March 30, 2022 due to his retirement; Due to job transfer, Ms. Chen Jinzhu, the former vice president, will no longer serve as the vice president of the company since March 30, 2022, but still serve as the Secretary of the board of directors of the company.

As of the date of this announcement, Mr. Gu Haoliang and Ms. Chen Jinzhu have no differences of opinion with the company and the board of directors, and there are no other matters that need to be brought to the attention of the shareholders of the company due to leaving office.

The board of directors of the company would like to express our heartfelt thanks to Mr. Gu Haoliang and Chen Jinzhu for their contributions to the company during their relevant tenure!

It is hereby announced.

Shanghai Pharmaceuticals Holding Co.Ltd(601607) board of directors

Attachment resume dated March 30, 2002:

Mr. Zhong Tao, born in June 1972, graduated from Fudan University with a master’s degree in business management. He is the director of the Party committee and the executive director of Shanghai Shencheng Pharmaceutical Group Co., Ltd., and the deputy director of Shanghai Shencheng Pharmaceutical Group Co., Ltd., and the executive director of Shanghai Shencheng Pharmaceutical Group Co., Ltd. He once served as the planning director of Shangshi Management (Shanghai) Co., Ltd., the assistant to the general manager of Shanghai Xinghe digital Investment Co., Ltd., and the project manager of the investment department of Shangshi real estate (Shanghai) Co., Ltd.

Mr. Li Dongming, born in September 1969, graduated from the Department of chemistry of Fudan University with a bachelor’s degree. He is currently the chief operating officer of Shanghai Baoji Pharmaceutical Co., Ltd. Former vice president and co president of Shanghai Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) (Group) Co., Ltd., senior vice president and general manager of overseas marketing headquarters of Shanghai Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) Industrial Development Co., Ltd., director and general manager of Shanghai Pharmaceuticals Holding Co.Ltd(601607) group drug sales Co., Ltd., director and general manager of Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd., director and deputy general manager of Shanghai Roche Pharmaceutical Co., Ltd, Vice president of OTC Business Department of Shanghai Pharmaceuticals Holding Co.Ltd(601607) (Group) Co., Ltd., director of strategic management of strategy and Investment Committee Office of board of directors of Shanghai Pharmaceuticals Holding Co.Ltd(601607) (Group) Co., Ltd., deputy general manager of Shanghai Yan’an Vientiane Pharmaceutical Co., Ltd., deputy factory director, assistant factory director and workshop director of Shanghai Yan’an pharmaceutical factory, etc.

Mr. Pan Deqing, born in July 1969, graduated from the Central Party school with a bachelor’s degree. At present, he is the deputy director of Shanghai Pharmaceuticals Holding Co.Ltd(601607) manufacturing management center, the party secretary and general manager of Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd. and the general manager of Shanghai Shangyao innovative pharmaceutical Co., Ltd. He once served as Deputy Secretary of the Party committee of Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd., executive vice president of Zhengda qingqingbao Pharmaceutical Co., Ltd., Secretary of the Party committee and deputy general manager of Shanghai Xinyi Pharmaceutical Co., Ltd., assistant to the president of the prescription drug division of Shanghai Pharmaceuticals Holding Co.Ltd(601607) (Group) Co., Ltd., Secretary of the Party committee and general manager of Shanghai Xinyi Vientiane Pharmaceutical Co., Ltd., deputy general manager of Shanghai Yan’an Vientiane Pharmaceutical Co., Ltd. and vice chairman of Shanghai Pharmaceutical Trade Union, Director of the party office of Shanghai Xinyi Pharmaceutical Co., Ltd. and director of the second workshop and solid preparation workshop.

- Advertisment -